Clinical trial
Trastuzumab and Vinorelbine in Advanced Breast Cancer
NCT01185509
Study timeline
Study start (actual)2010-11-01Date precision: month
Registry last updated2019-01-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Metastatic Breast Cancerunresolved
Interventions
trastuzumabDRUG · verified · RxNorm: trastuzumab
vinorelbineDRUG · verified · RxNorm: vinorelbine
Sponsors & collaborators
Dana-Farber Cancer Institutelead sponsor
Brigham and Women's Hospitalcollaborator
Beth Israel Deaconess Medical Centercollaborator
Massachusetts General Hospitalcollaborator
Genentech, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01185509 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.